Baloxavir Marboxil in Chinese Pediatric Patients Aged 1 to < 5 Years with Influenza: Safety and Clinical and Virologic Outcomes

Abstract Introduction Baloxavir marboxil (baloxavir), a cap-dependent endonuclease inhibitor, has been proven safe and efficacious against influenza and approved for the treatment of influenza in children aged ≥ 5 years in China. There were limited data on baloxavir in Chinese pediatric patients age...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuchuan Li, Peng Guo, Chenguang Jia, Ju Yin, Yuncui Yu, Qiang Qin, Xiaoyan Zhang, Shunying Zhao, Haiming Yang, Weihua Zhang, Yuguang Liang, Qian Ding, Man Tian, Yiping Chen, Chunmei Zhu, Fang Wang, Jing Ma, Lisu Huang, Yongping Xie, Jing Bi, Sainan Shu, Chengsong Zhao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2025-10-01
coleção:	Infectious Diseases and Therapy
Assuntos:	Baloxavir marboxil Children China Influenza virus infection Safety Viral shedding
Acesso em linha:	https://doi.org/10.1007/s40121-025-01253-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!